immuno-oncology

Immuno-Oncology Promises Continued Wealth And Health: LifeTech Capital’s Stephen Dunn

Immuno-Oncology Promises Continued Wealth And Health: LifeTech Capital’s Stephen Dunn
By iCELL News on February 20, 2015 · Investing
SummaryIn 2015, the focus of the checkpoint inhibitor space will be on additional cancer types, beyond melanoma, as well as on collaborations and combinations.
The financial resources needed to develop an advantage in the anti-PD-1/PD-L1 space are now beyond the reach of most smaller […]